# FDA recall Z-2675-2020

> **Boston Scientific Corporation** · Class II · device recall initiated 2020-06-04.

## Product

Ablation Galil Technology, IceFORCE 2.1 CX 90 Needle Cryoablation Needle, Prescription Only    Galil Medicals 2.1 CX Cryoablation Needles are intended for cryoablative destruction of tissue during surgical procedures.

## Reason for recall

The needle surface deteriorated due to unexpected electrolysis during procedure.

## Distribution

Nationwide Distribution to states of: AL, AR, AZ, CA,  CO, CT,  DE, DC, FL, GA, HI, IA, ID, KS, LA, MA, MD, ME, MN, MO, MS, NC, ND, NE, NJ, NM, NY,  NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI  WV, and WY and the country of: Canada.

## Key facts

- **Recall number:** Z-2675-2020
- **Recalling firm:** Boston Scientific Corporation
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2020-06-04
- **Report date:** 2020-07-29
- **Termination date:** 2024-09-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Marlborough, MA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2675-2020

## Citation

> AI Analytics. FDA recall Z-2675-2020. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/Z-2675-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*